Cite
HARVARD Citation
Nayak, T. et al. (n.d.). 304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRI. European journal of cancer. pp. S55-S56. [Online].